Global Intravenous Infusion Pump Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2029

                                          
Global Intravenous Infusion Pump Market 2021: By Product (Infusion pumps, Volumetric Infusion pumps, Insulin Infusion pumps, Syringe Infusion pumps, Enteral Infusion pumps, Ambulatory Infusion pumps, Patient Controlled Analgesics (PCA), Implantable Infusion pumps, Others), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others)

Global Intravenous Infusion Pump Market is the title of an upcoming report offered by Trusted Business Insights. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that - offers vital insights and perspectives in various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global intravenous infusion pump market has been segmented on the basis of product, disease indication, as well as regions and countries.

The Global Intravenous Infusion Pump market size was valued at USD $4.38 Billion in 2020, USD $4.71 Billion in 2021, forecasted to reach  USD $5.07 Billion in 2022, and is projected to reach USD $9.04 Billion by 2030, and is anticipated to expand at a CAGR of 7.5% over the forecast period from 2020 to 2030.

Overview:

An infusion pump infuses fluids medication, or nutrients into a patients circulatory system. It is generally used intravenously, although subcutaneous, epidural and arterial infusions are occasionally used. The pump is operated by a trained professional who adjusts settings to control the flow of rate and duration of fluid delivery.

Dynamics:

Intravenous infusion pumps are used extensively in clinical settings such as hospitals, nursing homes, or even at home. There are a host of primary factors that are fueling the current and future revenue growth of the intravenous infusion pump market. A major factor sustaining the market growth is the ever-growing global geriatric populations high risk of developing chronic diseases. The number of individuals aged 65 years and over, is expected to cross the 1.5 billion-mark by 2020. Another major factor that directly influences the global market is the increasing number of chronic disease cases. As a result of these diseases, most patients tend to undergo continuous treatment, and this is expected to boost revenue growth in the foreseeable future.

Other factors that are influencing the revenue growth of this market are the surging number of individuals undergoing surgical procedures and the rising demand for ambulatory intravenous infusion pumps.

Technological innovations have paved the way for smart pumps that have features such as various operator and patients safety features, drug libraries, and automation among others are expected to positively impact the adoption of these devices, and thereby, surge future market growth in the process.

Segmentation of the global intravenous infusion pump market is as follows:

On the basis of product, the ambulatory infusion pumps segment accounted for the majority revenue share of the global market due to the increasing demand for these supplies. Although, the implantable infusion pumps segment is expected to register the highest rate of revenue growth in the years to come as a result of the low incidence rate of delivery system failure, as well as the low incidence rate of infection.

In terms of disease indication, the pediatrics/neonatology segment accounted for the largest revenue share of the global intravenous infusion pump market in 2019. However, the hematology segment is expected to register the fastest rate of revenue growth in the foreseeable future. Owing to the rise in the number of surgeries being carried out globally, as well as the number of hemophilia cases being registered, the demand for treatments such as blood transfusions, etc. is expected to increase, and with it, the revenue growth of the global intravenous infusion pumps market.

Regional Segmentation and Analysis:

North America accounted for the majority revenue share of the global intravenous infusion pump market and is expected to continue to do so in the years to come. This can be accredited to factors such as the increasing adoption of advanced technology in intravenous pumps, the rising number of chronic diseases, a drastic increase in the number of surgical procedures being performed, as well as steady investments towards on-going R&D.

The markets in the Asia Pacific region are also expected to register a significant rate of revenue growth in the near future, due to the ever-increasing incidents of chronic diseases, lower upfront treatment costs and rising socio-economic factors in these countries.

Below are the active patents related to Intravenous Infusion Pump Market.

Patent Number: US8147448B2

High precision infusion pumps

Abstract

A system architecture for closed loop control of infusion devices is described. The architecture provides means to control the flow from an infusion device as well as in some embodiments the pressure of the delivery. A variety of infusion systems are described that use the closed loop control architecture. In some embodiments the closed loop control may be adapted to current commonly used infusion means such as a gravity feed intravenous system. Other embodiments describe infusion pump system that use biasing or drive mechanisms of springs, elastomers, rotary and linear motors.

Type: Grant

Filed: 2008-09-17

Date of Patent: 2012-04-03

Assignee : VTITAN Corp PRIVATE Ltd

Below are the leading companies profiled in this Intravenous Infusion Pump Market Report:

  
B. Braun Holding GmbH & Co. KG
  
Baxter International Inc.
  
Becton
  
Boston Scientific Corporation
  
CareFusion Corporation
  
Dickinson and Company
  
F. Hoffmann-La Roche Ltd.
  
Fresenius SE & Co. KGaA
  
ICU Medical Inc.
  
Medtronic
  
Micrel Medical Devices SA
  
Smiths Medical
  
Tandem Diabetes Care Inc.
  
Terumo Corporation

Segmentation of the Global Intravenous Infusion Pump Market:

By Product

  
Infusion pumps
  
Volumetric Infusion pumps
  
Insulin Infusion pumps
  
Syringe Infusion pumps
  
Enteral Infusion pumps
  
Ambulatory Infusion pumps
  
Patient Controlled Analgesics (PCA)
  
Implantable Infusion pumps
  
Others

By Disease Indication

  
Chemotherapy
  
Diabetes
  
Gastroenterology
  
Analgesia/Pain Management
  
Pediatrics/Neonatology
  
Hematology
  
Others
This research comprehensively answers the following 9 important questions:

  
Q.1. What are some of the most promising growth trends in the Intravenous Infusion Pump market worldwide?
  
Q.2.Which segments and sub-segments will grow at a faster pace and why? Which segment is nearing the peak and demand saturation?
  
Q.3.Which region will witness a higher growth rate and why? Which region might see a slower or negative growth region?
  
Q.4.What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in Intravenous Infusion Pump market?
  
Q.5.What are the business risks and who pose challenges to the global leaders and are competitive threats in this Intravenous Infusion Pump market?
  
Q.6.What are the emerging trends post COVID-19 reshuffle in this Intravenous Infusion Pump market and the what are reasons behind these trends and do they translate in global exploration?
  
Q.7. Who are the major global and regional players in the Intravenous Infusion Pump market? Which are the strategic initiatives key players are pursuing for business growth?
  
Q.8.Which are the competing products in Intravenous Infusion Pump market and how big of a threat do they pose for loss of market share by material or product substitution?
  
Q.9.What M & A activity has occurred in the last 5 years and what is its impact on the Intravenous Infusion Pump industry?